Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.
Cattedra Unesco - Educazione alla salute e allo sviluppo sostenibile, Università Federico II, Naples, Italy.
Obes Facts. 2021;14(2):222-245. doi: 10.1159/000515381. Epub 2021 Apr 21.
The very low-calorie ketogenic diet (VLCKD) has been recently proposed as an appealing nutritional strategy for obesity management. The VLCKD is characterized by a low carbohydrate content (<50 g/day), 1-1.5 g of protein/kg of ideal body weight, 15-30 g of fat/day, and a daily intake of about 500-800 calories.
The aim of the current document is to suggest a common protocol for VLCKD and to summarize the existing literature on its efficacy in weight management and weight-related comorbidities, as well as the possible side effects.
This document has been prepared in adherence with Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Literature searches, study selection, methodology development, and quality appraisal were performed independently by 2 authors and the data were collated by means of a meta-analysis and narrative synthesis.
Of the 645 articles retrieved, 15 studies met the inclusion criteria and were reviewed, revealing 4 main findings. First, the VLCKD was shown to result in a significant weight loss in the short, intermediate, and long terms and improvement in body composition parameters as well as glycemic and lipid profiles. Second, when compared with other weight loss interventions of the same duration, the VLCKD showed a major effect on reduction of body weight, fat mass, waist circumference, total cholesterol and triglyceridemia as well as improved insulin resistance. Third, although the VLCKD also resulted in a significant reduction of glycemia, HbA1c, and LDL cholesterol, these changes were similar to those obtained with other weight loss interventions. Finally, the VLCKD can be considered a safe nutritional approach under a health professional's supervision since the most common side effects are usually clinically mild and easily to manage and recovery is often spontaneous.
The VLCKD can be recommended as an effective dietary treatment for individuals with obesity after considering potential contra-indications and keeping in mind that any dietary treatment has to be personalized. Prospero Registry: The assessment of the efficacy of VLCKD on body weight, body composition, glycemic and lipid parameters in overweight and obese subjects: a meta-analysis (CRD42020205189).
极低卡路里生酮饮食(VLCKD)最近被提出作为一种有吸引力的肥胖管理营养策略。VLCKD 的特点是碳水化合物含量低(<50 克/天),理想体重 1-1.5 克/公斤蛋白质,15-30 克/天脂肪,每天摄入约 500-800 卡路里。
本文件旨在提出 VLCKD 的通用方案,并总结其在体重管理和与体重相关的合并症方面的有效性以及可能的副作用的现有文献。
本文件遵循系统评价和荟萃分析(PRISMA)指南制定。文献检索、研究选择、方法制定和质量评估由两名作者独立进行,数据通过荟萃分析和叙述性综合进行汇总。
从 645 篇文章中,有 15 项研究符合纳入标准并进行了审查,结果发现了 4 个主要发现。首先,VLCKD 在短期、中期和长期内均显示出显著的体重减轻,并改善了身体成分参数以及血糖和血脂谱。其次,与其他相同持续时间的减肥干预措施相比,VLCKD 对体重、脂肪量、腰围、总胆固醇和甘油三酯的降低以及改善胰岛素抵抗具有更大的影响。第三,尽管 VLCKD 也导致血糖、HbA1c 和 LDL 胆固醇显著降低,但这些变化与其他减肥干预措施相似。最后,VLCKD 可以被认为是一种安全的营养方法,只要在健康专业人员的监督下进行,因为最常见的副作用通常是临床轻微的,并且易于管理,并且恢复通常是自发的。
在考虑潜在禁忌症并记住任何饮食治疗都必须个性化的情况下,可以推荐 VLCKD 作为肥胖个体的有效饮食治疗。Prospéro 注册号:评估 VLCKD 对超重和肥胖受试者体重、身体成分、血糖和血脂参数的疗效:一项荟萃分析(CRD42020205189)。